Treating Hepatitus B Virus Infections
First Claim
Patent Images
1. A method of treating a subject against hepatitis B virus (HBV) infection, the method comprising administering to the subject a therapeutically effective amount of purified low density lipoprotein receptor (LDLR) or a LDLR inhibitor, thereby treating the subject against HBV infection.
1 Assignment
0 Petitions
Accused Products
Abstract
The specification provides compositions and methods of reducing a risk of a HBV infection in a subject and of treating a subject infected with HBV.
-
Citations
32 Claims
- 1. A method of treating a subject against hepatitis B virus (HBV) infection, the method comprising administering to the subject a therapeutically effective amount of purified low density lipoprotein receptor (LDLR) or a LDLR inhibitor, thereby treating the subject against HBV infection.
- 2. A method of treating a subject against HBV infection, the method comprising administering to the subject a therapeutically effective amount of purified low density lipoprotein receptor related protein (LRP) or a LRP inhibitor, thereby treating the subject against HBV infection.
- 3. A method of treating a subject against HBV infection, the method comprising administering to the subject a therapeutically effective amount of purified receptor associated protein (RAP), thereby treating the subject against HBV infection.
- 4. A method of treating a subject against a HBV infection, the method comprising administering to the subject a therapeutically effective amount of a FXa inhibitor, thereby treating the subject against HBV infection.
-
24. A composition comprising:
-
a therapeutically effective amount of purified LDLR, isolated LRP, isolated RAP, or any combination thereof; and a pharmaceutically acceptable carrier. - View Dependent Claims (25, 26, 27, 28, 29, 30, 31)
-
-
32-35. -35. (canceled)
Specification